Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL135474 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL31533290 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL8383575 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL7760915 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL1494603 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL51595 | 1.00 | TET2 (0.38) | TET2TDP1TGFBR1ALDH1A1HMGCR | |
| Methacrylic Acid SCHEMBL11681478 | 0.97 | TET2 (0.37) | TET2TDP1TGFBR1FFAR3LCK | |
| Methacrylic Acid SCHEMBL27965582 | 0.95 | TET2 (0.35) | TET2TDP1TGFBR1ALDH1A1 | |
| Methacrylic Acid SCHEMBL9635441 | 0.93 | TET2 (0.34) | TET2TDP1TGFBR1 | |
| Succinic Acid SCHEMBL1654074 | 0.91 | LMNA (0.42) | TET2TGFBR1HMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400223-A1 | DIGITAL EMBOSSING CREATION METHOD | Sakata INX Corporation (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-4397726-A1 | PHOTOCURABLE INK COMPOSITION FOR INKJET PRINTING | Sakata INX Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-20240218195-A1 | ELECTRON BEAM-CURABLE PRINTING INK COMPOSITION AND PRINTED MATTER OBTAINED BY PRINTING WITH ELECTRON BEAM-CURABLE PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240158652-A1 | ACTINIC-RAY-CURABLE INK COMPOSITION AND PRODUCTION METHOD THEREFOR | SAKATA INX CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| WO-2024095560-A1 | INK COMPOSITION FOR BLOCKING UV RAYS, AND METHOD FOR PRODUCING SUBSTRATE HAVING EMBOSSED SURFACE USING SAME | サカタインクス株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-4365250-A1 | MIGRATION-PREVENTING COATING AGENT | Sakata INX Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024089979-A1 | POWDER DEPOSITION PRINTING METHOD | サカタインクス株式会社 | 2024-05-02 | — | — | WO | disclosed |
| US-20240132734-A1 | ACTIVE ENERGY RAY-CURABLE OFFSET PRINTING INK COMPOSITION | SAKATA INX CORP (JP) | 2024-04-25 | — | — | US | disclosed |
| WO-2024075386-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION FOR SURFACE PRINTING | サカタインクス株式会社 | 2024-04-11 | — | — | WO | disclosed |
| US-11932767-B2 | Active energy ray curable ink composition and method for manufacturing printed matter using same | SAKATA INX CORPORATION (JP) | 2024-03-19 | — | — | US | disclosed |
| US-20150050231-A1 | HAIR COSMETIC | KOSE CORPORATION (JP) | 2015-02-19 | — | — | US | disclosed |
| US-8901265-B2 | Cationic (meth) acrylic silicone-based graft copolymer and cosmetic containing same | KOSE CORPORATION (JP) | 2014-12-02 | — | — | US | disclosed |
| EP-2177577-B1 | INK CURABLE WITH ACTINIC ENERGY RAY AND PRINTED MATTER | TOYO INK MFG CO (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-20140018508-A1 | CATIONIC (METH) ACRYLIC SILICONE-BASED GRAFT COPOLYMER AND COSMETIC CONTAINING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-01-16 | — | — | US | disclosed |
| US-8362100-B2 | Ink curable with actinic energy ray and printed matter | TOKYO INK MFG. CO., LTD. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-7928322-B2 | Conductive ink, conductive circuit and non-contact media | TOYO INK MFG. CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20100304098-A1 | INK CURABLE WITH ACTINIC ENERGY RAY AND PRINTED MATTER | TOYO INK MFG. CO., LTD. (JP) | 2010-12-02 | — | — | US | disclosed |
| EP-2177577-A1 | INK CURABLE WITH ACTINIC ENERGY RAY AND PRINTED MATTER | Toyo Ink Manufacturing CO., LTD. (JP) | 2010-04-21 | — | — | EP | disclosed |
| US-20100051333-A1 | CONDUCTIVE INK, CONDUCTIVE CIRCUIT AND NON-CONTACT MEDIA | TOYO INK MFG. CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| US-5077356-A | Binder for printing inks; phenolic hydrocarbon resins, polyiso cyanates, and unsaturated reactants | NIPPON OIL COMPANY, LTD. (JP) | 1991-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018508-A1 | CATIONIC (METH) ACRYLIC SILICONE-BASED GRAFT COPOLYMER AND COSMETIC CONTAINING SAME | ALG3, MMAB, ACMSD | TET2 138/4885TDP1 2873/4885TGFBR1 1598/4885 |
| US-20150050231-A1 | HAIR COSMETIC | CUTA, MMAB, FHIT | TET2 14/4885TDP1 3768/4885TGFBR1 3693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.